China HeadAche DIsorders RegiStry (NCT05334927) | Clinical Trial Compass
RecruitingNot Applicable
China HeadAche DIsorders RegiStry
China10,000 participantsStarted 2022-08-29
Plain-language summary
It is planned to include 10000 patients. In the China HeadAche DIsorders RegiStry CHAIRS）, patients aged over 12 years with primary headache and medication-overuse headache(MOH) were collected. The biomarkers, imaging features, cognition, genetic characteristics, ocial and demographic data, medical data, therapeutics used, and outcome of headache-related diseases were studied, and long-term follow-up was planned.
Who can participate
Age range12 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Age ≥ 12 years old,Any gender;
✓. The first onset age of primary headache was less than 50 years old(Age \<65 years at first diagnosis of chronic migraine);
✓. patients with primary headache (migraine, tension headache and other types of primary headache) or primary headache complicated with MOH according to ICHD-3;
✓. Sign the informed consent form.
Exclusion criteria
✕. According to the ICHD-3 diagnostic criteria, there are still headaches directly related to secondary factors (except drug overuse) at the time of enrollment;
✕. Those who cannot be diagnosed as primary headache or primary headache combined with medication overuse headache according to ICHD-3;
✕. According to DSM-V diagnostic criteria, patients with severe mental diseases (such as schizophrenia, mental disorders associated with mental retardation, etc.);
✕. Patients with severe organic diseases, such as malignant tumors, and the expected survival time is less than 1 year;
✕. Pregnant,planning pregnancy or Lactating women;
✕. Subjects participating in other clinical trials;
✕. Unable to cooperate to complete the follow-up due to geographical or other reasons